Higher Engagement With Chat-Based Smoking Intervention Boosts Abstinence Rates

Follow Drugslib on

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

FRIDAY, July 5, 2024 -- Higher levels of engagement with a chat-based smoking cessation intervention are associated with greater biochemically validated tobacco abstinence at three and six months, according to a study published online June 26 in JAMA Network Open.

Yajie Li, from the School of Nursing at the University of Hong Kong, and colleagues conducted a secondary analysis of a cluster randomized clinical trial involving 624 cigarette smokers receiving chat-based smoking cessation support via mobile instant messaging for three months.

The researchers identified four distinct engagement trajectories: a low engagement group (71.6 percent), in which participants maintained very low engagement throughout; rapid-declining group (13.8 percent), in which participants began with moderate engagement and rapidly decreased to a low level; gradual-declining group (9.3 percent), in which participants had high initial engagement that gradually decreased to a moderate level; and high engagement group (5.3 percent), in which participants maintained high engagement throughout. The six-month validated abstinence rates were significantly higher in the rapid-declining group (adjusted relative risk [aRR], 3.30), gradual-declining group (aRR, 5.17), and high engagement group (aRR, 4.98) compared with the low engagement group. For three-month validated abstinence, the corresponding aRRs were 4.03, 5.25, and 9.23.

"Improving engagement with digital interventions may increase intervention benefits," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-07-06 01:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords